Teresa H Kuan

US Patent:

6492361, Dec 10, 2002

Filed:

Oct 5, 2000

Appl. No.:

09/680810

Inventors:

Christopher A. Muller - Foothill Ranch CA
Elizabeth A. Bancroft - Irvine CA
Janet K. Cheetham - Laguna Niguel CA
Harold G. Jensen - Lake Forest CA
Teresa H. Kuan - Placentia CA
David F. Power - Trabuco Canyon CA
Kevin D. Skule - Rancho Santa Margarita CA

Assignee:

Allergan Sales, Inc - Irvine CA

International Classification:

A62K 3902

US Classification:

5142355, 514250, 514254, 514912

Abstract:

Compositions including a quinolone component in an amount effective as an antibiotic when the composition is placed in a mammalian eye, and a carrier component in an amount effective to act as a carrier for the quinolone component are provided. The present compositions are substantially free of other components effective as preservatives. Preferably the quinolone component has fungistatic activity. In one very useful embodiment, the compositions include a NSAID component in an amount effective to reduce inflammation or pain when the composition is placed in a mammalian eye. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention.

US Patent:

6552020, Apr 22, 2003

Filed:

Jul 24, 2000

Appl. No.:

09/624129

Inventors:

Christopher A. Muller - Foothill Ranch CA
Elizabeth A. Bancroft - Irvine CA
Janet K. Cheetham - Laguna Niguel CA
Harold G. Jensen - Lake Forest CA
Teresa H. Kuan - Placentia CA
David F. Power - Trabuco Canyon CA
Kevin D. Skule - Rancho Santa Margarita CA

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 31535

US Classification:

5142355, 514250, 514912

Abstract:

Compositions including a quinolone component, such as ofloxacin, having fungistatic activity in the compositions, present in an amount effective as an antibiotic when the composition is placed in a mammalian eye, a NSAID component present in an amount to reduce inflammation or pain when the composition is placed in the eye, and a carrier component in an amount effective to act as a carrier for the quinolone component and NSAID component are provided. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention. Methods for treating corneal injuries are also included. In addition, methods for treating ocular infections, for example, corneal infections, are included.

US Patent:

7045121, May 16, 2006

Filed:

Dec 14, 2001

Appl. No.:

10/017817

Inventors:

James N. Chang - Newport Beach CA, US
Teresa H. Kuan - Placentia CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 31/47

US Classification:

424 7804, 514 57, 514912

Abstract:

Ophthalmic compositions include an ophthalmically acceptable carrier component, for example, an aqueous-based carrier, and a plurality of polyanionic component portions having different molecular weights. In one embodiment, the polyanionic component includes a first polyanionic component portion having a first molecular weight; and a second polyanionic component portion having a different second molecular weight. Each of the first and second polyanionic component portions is present in an amount effective to provide lubrication to an eye when the composition is administered to an eye. Methods of making and using such compositions are also disclosed.

US Patent:

7810643, Oct 12, 2010

Filed:

Jul 7, 2006

Appl. No.:

11/483039

Inventors:

Bruce A. Firestone - Irvine CA, US
John Jacob Vander Zanden - Edina MN, US
Rodney J. Terwilliger - Buena Park CA, US
Janet K. Cheetham - Laguna Niguel CA, US
Richard Kurjan - Huntington Beach CA, US
Teresa Kuan - Placentia CA, US
Chin-Ming Chang - Tustin CA, US
J. Abraham M. Le Espiritu - Oceanside CA, US

Assignee:

Allergan, Inc. - IRvine CA

International Classification:

B65D 83/04
A61K 9/00
A61K 31/13

US Classification:

206534, 206531, 206532, 206539, 424400, 514662

Abstract:

A titration package and method for enabling compliance with a regimen of changing dosage of medication over a period of time includes a backing having an array of receivers with the array including a plurality of columns and a plurality of rows. A plurality of sets of Memantine tablets are provided with each tablet set having a common dose of medication and a different does than a tablet of a different set. Each set of tablets is disposed in receivers of one having an adjacent row and an adjacent column. Indicia is provided and disposed adjacent to the columns and rows for displaying common days and successive weeks.

US Patent:

8008338, Aug 30, 2011

Filed:

May 28, 2004

Appl. No.:

10/856192

Inventors:

Christopher A. Muller - Foothill Ranch CA, US
Janet K. Cheetham - Laguna Niguel CA, US
Teresa H. Kuan - Placentia CA, US
David F. Power - Trabuco Canyon CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 31/40

US Classification:

514413, 514912

Abstract:

Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0. 5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.

US Patent:

8377982, Feb 19, 2013

Filed:

Mar 30, 2012

Appl. No.:

13/434956

Inventors:

Christopher A. Muller - Foothill Ranch CA, US
Janet K. Cheetam - Laguna Niguel CA, US
Teresa H. Kuan - Placentia CA, US

Assignee:

Allergan Sales, LLC - Irvine CA

International Classification:

A61K 31/40

US Classification:

514413, 514912

Abstract:

Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0. 5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.

US Patent:

8512717, Aug 20, 2013

Filed:

Aug 5, 2004

Appl. No.:

10/911966

Inventors:

Joseph G. Vehige - Laguna Niguel CA, US
James N. Chang - Newport Beach CA, US
Richard Graham - Irvine CA, US
Robert T. Lyons - Laguna Hills CA, US
Teresa H. Kuan - Placentia CA, US
Chin-Ming Chang - Tustin CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 9/00
A61K 31/40

US Classification:

424400, 514413

Abstract:

The present invention provides for compositions for administering a therapeutically effective amount of a therapeutic component. The compositions may include an ophthalmically acceptable carrier component; a therapeutically effective amount of a therapeutic component; and a retention component which may be effective to reduce wettability, induce viscosity, increase muco-adhesion, increase meniscus height on a cornea of an eye and/or increase physical apposition to a cornea of an eye of a composition.

US Patent:

8541463, Sep 24, 2013

Filed:

Jan 14, 2013

Appl. No.:

13/740426

Inventors:

Janet K. Cheetham - Laguna Niguel CA, US
Teresa H. Kuan - Placentia CA, US
David F. Power - Trabuco Canyon CA, US

Assignee:

Allergan Sales, LLC - Irvine CA

International Classification:

A61K 31/40

US Classification:

514413, 514912

Abstract:

Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0. 5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.